Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Robotic Bronchoscope System Enables Minimally Invasive Pulmonary Lesions Sampling

By HospiMedica International staff writers
Posted on 17 Apr 2023

Cancer is well-known for its high mortality rate and rising global incidence. More...

Lung cancer is particularly devastating and was the second most common cancer worldwide in 2020, according to the World Cancer Research Fund International. Over 2.2 million new cases and 1.8 million deaths were reported that year. However, like other cancers, lung cancer is more treatable if detected early.

Researchers at the Beijing Institute of Technology (Beijing, China) have developed an innovative robotic bronchoscope system that non-invasively accesses lung areas for minimally invasive pulmonary lesion sampling, the gold standard for lung cancer diagnosis. To accurately target the lesion of interest, the end effector's position and pose must be determined in real-time. The researchers tackled this issue by creating a navigation system that attaches an endoscope and two electromagnetic sensors to the end effector, enabling online positioning for navigation and supplying visual information for doctors to diagnose and sample.

The navigation system also constructs a three-dimensional virtual model based on computed tomography for robotic path planning, allowing for the selection of the target area. By combining the flexible end effector with the navigation system, the robotic bronchoscope system can automatically reach the target lesion and offer intraoperative visual guidance for biopsy sampling. The researchers verified the feasibility of the robotic bronchoscope system through an ex vivo navigation-assisted intervention experiment. The position displayed by the virtual endoscope's third perspective matched the end effector's tip position relative to the airway phantom, as observed visually. The virtual endoscope view also matched the real video captured by the endoscope module, as anticipated by the researchers. Going forward, the researchers plan to reduce the end effector's diameter, adopt replaceable modules for various surgical needs, explore joint control for more flexible robot movement in the airway, and implement computer vision algorithms for automatic and intelligent calibration.

“Imagine inserting a long thin line into your mouth, through your airway to cut a little part of the lesion of interest within your lung. After that, this thin line brings the cut sample back for further examination to determine whether it’s benign or malignant,” said the researchers, “This is what the bronchoscope system was designed for.”

Related Links:
Beijing Institute of Technology 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.